Human Gene MIR193B (ENST00000384907.1) from GENCODE V44
  Description: Homo sapiens microRNA 193b (MIR193B), microRNA. (from RefSeq NR_030177)
RefSeq Summary (NR_030177): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage.
Gencode Transcript: ENST00000384907.1
Gencode Gene: ENSG00000207639.1
Transcript (Including UTRs)
   Position: hg38 chr16:14,303,967-14,304,049 Size: 83 Total Exon Count: 1 Strand: +


Page IndexSequence and LinksPrimersCTDRNA-Seq ExpressionMicroarray Expression
Other SpeciesmRNA DescriptionsOther NamesMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr16:14,303,967-14,304,049)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaBioGPS
EnsemblEntrez GeneExonPrimerGencodeHGNCLynx
MalacardsOMIMPubMedBioGrid CRISPR DB

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.00 RPKM in Adipose - Subcutaneous
Total median expression: 0.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  DM175399 - A nucleics Acid regulating cell growth.
FZ435759 - JP 2011501949-A/76: DIAGNOSIS AND PROGNOSIS OF SPECIFIC CANCERS.
HH826050 - Sequence 3 from Patent WO2010100328.
HI979106 - Sequence 33 from Patent EP2234483.
HV342488 - JP 2011510623-A/33: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY.
HW101991 - JP 2013500034-A/118: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW505268 - JP 2014502606-A/170: MELANOMA TREATMENTS.
HZ043354 - JP 2015510401-A/444: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ081980 - JP 2015514392-A/444: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ408324 - JP 2015528002-A/921: CHIRAL CONTROL.
LF404451 - JP 2015509366-A/444: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LG051658 - KR 1020150036642-A/924: CHIRAL CONTROL.
LZ215740 - JP 2017518753-A/91: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
MA353982 - JP 2018075017-A/444: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MP045622 - Sequence 444 from Patent EP3401394.
MP084292 - Sequence 444 from Patent EP3401393.
FV524033 - Diagnosis and therapeutic choice of gynecologic cancer using micro RNA as biomarker.
FW364088 - Oligonucleotides for modulating target RNA activity.
FW393822 - Diagnosis and therapeutic choice of gynecologic cancer using micro RNA as biomarker.
HI560974 - Sequence 189 from Patent EP2190992.
HI965340 - Sequence 625 from Patent WO2010139812.
HI966522 - Sequence 842 from Patent WO2010139811.
HI967388 - Sequence 842 from Patent WO2010139810.
HI979081 - Sequence 8 from Patent EP2234483.
HV342463 - JP 2011510623-A/8: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY.
HV555488 - JP 2012016294-A/4: Composition or kit for determining sensitivity to auxiliary chemotherapy of stomach cancer.
HV594075 - JP 2010538653-A/189: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV594993 - JP 2010539959-A/374: Micromirs.
HW044131 - WO 2012161124-A/4: A composition comprising a miRNA or an expression system of said miRNA.
HW101939 - JP 2013500034-A/66: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW413587 - WO 2014003053-A/36: Method for screening pancreatic cancer and test kit therefor.
HW505595 - JP 2014502606-A/497: MELANOMA TREATMENTS.
HW914652 - JP 2015504847-A/6: TARGETING MICRORNAS MIR-409-5P, MIR-379 AND MIR-154* TO TREAT PROSTATE CANCER BONE METASTASIS AND DRUG RESISTANT LUNG CANCER.
HZ074309 - JP 2013535982-A/400: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ083203 - JP 2015513906-A/560: Stem Cell Microparticles.
HZ157550 - JP 2015130862-A/374: Micromirs.
HZ186401 - JP 2015146814-A/150: Oligonucleotides for modulating target RNA activity.
HZ436984 - JP 2015529450-A/560: Stem Cell Microparticles.
HZ479900 - JP 2015535430-A/406: TERMINALLY MODIFIED RNA.
HZ789831 - JP 2016504050-A/1576: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287384 - Sequence 66 from Patent WO2011015720.
JA401378 - Sequence 625 from Patent WO2011080318.
JA402356 - Sequence 625 from Patent WO2011080315.
JA403363 - Sequence 625 from Patent WO2011080316.
JA405994 - Sequence 625 from Patent EP2336353.
JA426731 - Sequence 64 from Patent WO2011072177.
JA429520 - Sequence 625 from Patent WO2011095623.
JA791631 - Sequence 33 from Patent WO2012089772.
JB022272 - Sequence 114 from Patent WO2013026685.
JB022854 - Sequence 108 from Patent WO2013026684.
JB620485 - Sequence 465 from Patent WO2013063544.
JB624369 - Sequence 189 from Patent EP2610342.
JB835815 - Sequence 105 from Patent WO2013057567.
JC172188 - Sequence 560 from Patent WO2013150303.
JC244516 - Sequence 136 from Patent WO2012020308.
JC512563 - Sequence 2816 from Patent WO2014113089.
JC572999 - Sequence 560 from Patent WO2014125276.
JC582687 - Sequence 560 from Patent WO2014125277.
JE954383 - Sequence 560 from Patent WO2015052526.
JE956136 - Sequence 560 from Patent WO2015052527.
JE988588 - Sequence 37 from Patent WO2015121417.
LF137888 - JP 2016507550-A/560: Method of Producing Microparticles.
LF161285 - JP 2016513950-A/1351: Oligomers with improved off-target profile.
LF162853 - JP 2016513095-A/560: Stem Cell Microparticles and miRNA.
LF644417 - JP 2016144439-A/8: Method for assessing cell aging.
LF953605 - JP 2016534103-A/560: Stem Cell Microparticles and miRNA.
LG005950 - KR 1020150004822-A/560: STEM CELL MICROPARTICLES.
LG053646 - KR 1020150059168-A/560: STEM CELL MICROPARTICLES.
LG240885 - KR 1020160035087-A/560: STEM CELL MICROPARTICLES AND MIRNA.
LP714643 - Sequence 15 from Patent WO2015092707.
LP727148 - Sequence 842 from Patent EP2883966.
LP819418 - Sequence 842 from Patent EP3296406.
LP939360 - Sequence 842 from Patent EP3184651.
LQ070151 - Sequence 475 from Patent EP2964234.
LQ724415 - Sequence 48 from Patent WO2018096084.
LQ955611 - Sequence 6 from Patent EP2785355.
LV470970 - JP 2016534036-A/560: Stem Cell Microparticles and miRNA.
LY405058 - KR 1020160117535-A/363: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233758 - JP 2017184756-A/150: Oligonucleotides for modulating target RNA activity.
MA260297 - JP 2017505623-A/363: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA406037 - WO 2018155427-A/811: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA643652 - JP 2017113010-A/1576: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731536 - JP 2017140048-A/406: TERMINALLY MODIFIED RNA.
MS673305 - Sequence 108 from Patent EP3135774.
MS833484 - Sequence 189 from Patent EP3112464.
MS834479 - Sequence 625 from Patent EP3112479.
MS901641 - Sequence 114 from Patent EP3156505.
MS930522 - Sequence 15 from Patent EP3178943.
EF100863 - Homo sapiens microRNA miR-193c, complete sequence.
FZ421171 - JP 2010539978-A/71: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF.
HW502485 - JP 2014050389-A/71: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF.
AY882278 - Homo sapiens microRNA HSA-MIR-RG-49, complete sequence.
FW364087 - Oligonucleotides for modulating target RNA activity.
FW371751 - Human-derived nuclear acids for inhibiting HIV protein expression.
FZ435744 - JP 2011501949-A/61: DIAGNOSIS AND PROGNOSIS OF SPECIFIC CANCERS.
HH826073 - Sequence 26 from Patent WO2010100328.
HI560973 - Sequence 188 from Patent EP2190992.
HI965341 - Sequence 626 from Patent WO2010139812.
HI965850 - Sequence 170 from Patent WO2010139811.
HI966716 - Sequence 170 from Patent WO2010139810.
HV335769 - JP 2011093892-A/12: Tumor proliferation suppressor comprising tumor suppressive micro RNA.
HV543912 - JP 2011217617-A/23: Method for testing fibrosis of chronic liver diseases using miRNAs.
HV593860 - JP 2010538610-A/73: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
HV594074 - JP 2010538653-A/188: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV594992 - JP 2010539959-A/373: Micromirs.
HW101887 - JP 2013500034-A/14: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW151472 - WO 2013047815-A/17: ENDOPLASMIC RETICULUM STRESS MODULATOR.
HW505457 - JP 2014502606-A/359: MELANOMA TREATMENTS.
HW608535 - JP 2014515024-A/24: Micro-RNA Inhibitors and Their Uses in Disease.
HW669785 - JP 2013537538-A/516: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
HW823970 - JP 2015502176-A/31: Methods and Kits for Detecting Subjects at Risk of Having Cancer.
HW913252 - JP 2015504307-A/12: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HW914651 - JP 2015504847-A/5: TARGETING MICRORNAS MIR-409-5P, MIR-379 AND MIR-154* TO TREAT PROSTATE CANCER BONE METASTASIS AND DRUG RESISTANT LUNG CANCER.
HZ043319 - JP 2015510401-A/409: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ043375 - JP 2015510401-A/465: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ074310 - JP 2013535982-A/401: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ081945 - JP 2015514392-A/409: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ082001 - JP 2015514392-A/465: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ082791 - JP 2015513906-A/148: Stem Cell Microparticles.
HZ157549 - JP 2015130862-A/373: Micromirs.
HZ186400 - JP 2015146814-A/149: Oligonucleotides for modulating target RNA activity.
HZ436572 - JP 2015529450-A/148: Stem Cell Microparticles.
HZ479899 - JP 2015535430-A/405: TERMINALLY MODIFIED RNA.
HZ789830 - JP 2016504050-A/1575: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287332 - Sequence 14 from Patent WO2011015720.
JA401379 - Sequence 626 from Patent WO2011080318.
JA402357 - Sequence 626 from Patent WO2011080315.
JA403364 - Sequence 626 from Patent WO2011080316.
JA405995 - Sequence 626 from Patent EP2336353.
JA426889 - Sequence 222 from Patent WO2011072177.
JA429521 - Sequence 626 from Patent WO2011095623.
JA660813 - Sequence 267 from Patent WO2011131354.
JA682675 - Sequence 143 from Patent WO2011149354.
JB158036 - Sequence 24 from Patent WO2012142313.
JB620486 - Sequence 466 from Patent WO2013063544.
JB624368 - Sequence 188 from Patent EP2610342.
JB778633 - Sequence 12 from Patent WO2013078283.
JC037650 - Sequence 178 from Patent EP2643479.
JC171776 - Sequence 148 from Patent WO2013150303.
JC244517 - Sequence 137 from Patent WO2012020308.
JC244861 - Sequence 489 from Patent WO2012020308.
JC244947 - Sequence 575 from Patent WO2012020308.
JC270125 - Sequence 516 from Patent WO2012020307.
JC512562 - Sequence 2815 from Patent WO2014113089.
JC572587 - Sequence 148 from Patent WO2014125276.
JC582275 - Sequence 148 from Patent WO2014125277.
JE953971 - Sequence 148 from Patent WO2015052526.
JE955724 - Sequence 148 from Patent WO2015052527.
JE978822 - Sequence 267 from Patent EP2865765.
LF137476 - JP 2016507550-A/148: Method of Producing Microparticles.
LF161162 - JP 2016513950-A/1228: Oligomers with improved off-target profile.
LF162441 - JP 2016513095-A/148: Stem Cell Microparticles and miRNA.
LF404416 - JP 2015509366-A/409: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF636285 - JP 2016519076-A/59: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF857624 - JP 2015130879-A/73: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
LF953193 - JP 2016534103-A/148: Stem Cell Microparticles and miRNA.
LG005538 - KR 1020150004822-A/148: STEM CELL MICROPARTICLES.
LG053234 - KR 1020150059168-A/148: STEM CELL MICROPARTICLES.
LG134442 - KR 1020150131312-A/59: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG240473 - KR 1020160035087-A/148: STEM CELL MICROPARTICLES AND MIRNA.
LP726476 - Sequence 170 from Patent EP2883966.
LP818746 - Sequence 170 from Patent EP3296406.
LP938688 - Sequence 170 from Patent EP3184651.
LQ070150 - Sequence 474 from Patent EP2964234.
LQ244871 - Sequence 10 from Patent WO2016040242.
LQ245135 - Sequence 10 from Patent WO2016040246.
LQ500659 - Sequence 73 from Patent EP3048177.
LQ955610 - Sequence 5 from Patent EP2785355.
LQ955742 - Sequence 73 from Patent EP2775001.
LQ970621 - Sequence 31 from Patent EP2800820.
LV470558 - JP 2016534036-A/148: Stem Cell Microparticles and miRNA.
LV539175 - JP 2016539127-A/176: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE.
LX270582 - JP 2016056210-A/516: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
LY298577 - KR 1020160079824-A/176: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE.
LY405057 - KR 1020160117535-A/362: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY416912 - KR 1020160145093-A/18: USE OF MICRO-RIBONUCLEIC ACID(MIRNA) TO DIAGNOSE TRANSPLANT REJECTION AND TOLERANCE OF IMMUNOSUPPRESSION THERAPY.
LY504791 - KR 1020170035932-A/180: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ215693 - JP 2017518753-A/44: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
LZ233757 - JP 2017184756-A/149: Oligonucleotides for modulating target RNA activity.
LZ243072 - JP 2017525350-A/180: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ993005 - JP 2017532547-A/9: METHODS FOR INHIBITING HMGB1 ACTIVATION OF MELANOCYTES, METHOD FOR IDENTIFICATION OF AGENTS SUITABLE FOR SUCH INHIBITON.
MA260296 - JP 2017505623-A/362: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA353947 - JP 2018075017-A/409: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MA405734 - WO 2018155427-A/508: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA419978 - JP 2018518169-A/29: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420056 - JP 2018518169-A/107: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420088 - JP 2018518169-A/139: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420105 - JP 2018518169-A/156: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420130 - JP 2018518169-A/181: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420164 - JP 2018518169-A/215: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420186 - JP 2018518169-A/237: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA643651 - JP 2017113010-A/1575: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA730729 - JP 2017125065-A/516: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
MA731535 - JP 2017140048-A/405: TERMINALLY MODIFIED RNA.
MP045587 - Sequence 409 from Patent EP3401394.
MP075739 - Sequence 78 from Patent WO2019002265.
MP084257 - Sequence 409 from Patent EP3401393.
MP084313 - Sequence 465 from Patent EP3401393.
MS833483 - Sequence 188 from Patent EP3112464.
MS834480 - Sequence 626 from Patent EP3112479.
MS837410 - Sequence 5 from Patent EP3121289.
MS904157 - Sequence 73 from Patent EP3138926.
MS944924 - Sequence 180 from Patent EP3177739.
CS548324 - Sequence 1354 from Patent EP1777301.
DM174454 - A nucleics Acid regulating cell growth.
FW312066 - DETECTING NUCLEIC ACIDS.
HV534422 - WO 2011111715-A/938: Nucleic acid for controlling cell cycle.
JC334388 - Sequence 306 from Patent EP2487240.
LP636962 - Sequence 12 from Patent EP2848702.
MA800705 - JP 2018183181-A/1576: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800704 - JP 2018183181-A/1575: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MP129660 - Sequence 560 from Patent EP3470073.
MP133786 - Sequence 3 from Patent WO2019038456.
MP162583 - Sequence 560 from Patent WO2019069093.
MP129248 - Sequence 148 from Patent EP3470073.
MP133787 - Sequence 4 from Patent WO2019038456.
MP162171 - Sequence 148 from Patent WO2019069093.
MP168034 - Sequence 41 from Patent EP3469101.
MA886370 - WO 2019049612-A/10: An antitumor agent, food and beverage for prevention of cancer and an agent for increasing expression of tumor-suppressive microRNA.
MA989570 - JP 2017530116-A/9: METHOD OF MAKING A SKIN CARE COMPOSITION.
MP280603 - Sequence 23 from Patent WO2019111197.
MP283516 - Sequence 23 from Patent WO2019111198.
MB407045 - WO 2019159884-A/535: Kit, device, and method for detection of dementia.
MB407445 - WO 2019159884-A/935: Kit, device, and method for detection of dementia.
MB406646 - WO 2019159884-A/136: Kit, device, and method for detection of dementia.
MB420640 - JP 2019154320-A/8: Method for evaluating cell quality.
MB481461 - JP 2019528758-A/41: Methods And Compositions For Prostate Cancer Diagnosis And Treatment.
MP325463 - Sequence 10 from Patent EP3536789.
MP335219 - Sequence 1 from Patent WO2019185823.
MP337292 - Sequence 1 from Patent EP3546597.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_030177, uc021tdg.1
UCSC ID: ENST00000384907.1
RefSeq Accession: NR_030177

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.